Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Volin

Showing results (61-70 of 131) with videos related to

Pageof 14
Sort By:
Bone Marrow Transplantation|April 1, 1997
Incidence and risk factors for invasive fungal infections in allogeneic BMT recipientsE Jantunen, P Ruutu, L Niskanen, et al.
Bone Marrow Transplantation|March 16, 2002
Radiologically guided fine needle lung biopsies in the evaluation of focal pulmonary lesions in allogeneic stem cell transplant recipientsE Jantunen, A Piilonen, L Volin, et al.
Scandinavian Journal of Immunology|June 19, 2012
Toll-like receptor gene polymorphisms confer susceptibility to graft-versus-host disease in allogenic hematopoietic stem cell transplantationJ Sivula, Z M Cordova, J Tuimala, et al.
Leukemia|May 1, 1997
Follow-up of residual disease using metaphase-FISH in patients with acute lymphoblastic leukemia in remissionW El-Rifai, T Ruutu, K Vettenranta, et al.
Bone Marrow Transplantation|September 1, 2009
Early thrombin generation and impaired fibrinolysis after SCT associate with acute GVHDA Pinomäki, L Volin, L Joutsi-Korhonen, et al.
European Journal of Haematology|March 21, 1998
Successful treatment of platelet transfusion refractoriness: the use of platelet transfusions matched for both human leucocyte antigens (HLA) and human platelet alloantigens (HPA) in alloimmunized patients with leukaemiaS Kekomäki, L Volin, P Koistinen, et al.
Bone Marrow Transplantation|September 22, 1999
IgG subclasses and avidity of antibodies to polysaccharide antigens in allogeneic BMT recipients after vaccination with pneumococcal polysaccharide and Haemophilus influenzae type b conjugate vaccinesT Parkkali, H Käyhty, M Anttila, et al.
Bone Marrow Transplantation|March 7, 2003
Central nervous system aspergillosis in allogeneic stem cell transplant recipientsE Jantunen, L Volin, O Salonen, et al.
Bone Marrow Transplantation|June 1, 1990
Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation GroupN Jacobsen, J H Badsberg, B Lönnqvist, et al.
Bone Marrow Transplantation|May 16, 2006
Autologous stem cell transplantation in patients with chronic lymphocytic leukaemia: the Finnish experienceE Jantunen, M Itälä, T Siitonen, et al.
Pageof 14

Showing results (61-70 of 131) with videos related to

Sort By:
Pageof 14
Bone Marrow Transplantation|April 1, 1997
Incidence and risk factors for invasive fungal infections in allogeneic BMT recipientsE Jantunen, P Ruutu, L Niskanen, et al.
Bone Marrow Transplantation|March 16, 2002
Radiologically guided fine needle lung biopsies in the evaluation of focal pulmonary lesions in allogeneic stem cell transplant recipientsE Jantunen, A Piilonen, L Volin, et al.
Scandinavian Journal of Immunology|June 19, 2012
Toll-like receptor gene polymorphisms confer susceptibility to graft-versus-host disease in allogenic hematopoietic stem cell transplantationJ Sivula, Z M Cordova, J Tuimala, et al.
Leukemia|May 1, 1997
Follow-up of residual disease using metaphase-FISH in patients with acute lymphoblastic leukemia in remissionW El-Rifai, T Ruutu, K Vettenranta, et al.
Bone Marrow Transplantation|September 1, 2009
Early thrombin generation and impaired fibrinolysis after SCT associate with acute GVHDA Pinomäki, L Volin, L Joutsi-Korhonen, et al.
European Journal of Haematology|March 21, 1998
Successful treatment of platelet transfusion refractoriness: the use of platelet transfusions matched for both human leucocyte antigens (HLA) and human platelet alloantigens (HPA) in alloimmunized patients with leukaemiaS Kekomäki, L Volin, P Koistinen, et al.
Bone Marrow Transplantation|September 22, 1999
IgG subclasses and avidity of antibodies to polysaccharide antigens in allogeneic BMT recipients after vaccination with pneumococcal polysaccharide and Haemophilus influenzae type b conjugate vaccinesT Parkkali, H Käyhty, M Anttila, et al.
Bone Marrow Transplantation|March 7, 2003
Central nervous system aspergillosis in allogeneic stem cell transplant recipientsE Jantunen, L Volin, O Salonen, et al.
Bone Marrow Transplantation|June 1, 1990
Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation GroupN Jacobsen, J H Badsberg, B Lönnqvist, et al.
Bone Marrow Transplantation|May 16, 2006
Autologous stem cell transplantation in patients with chronic lymphocytic leukaemia: the Finnish experienceE Jantunen, M Itälä, T Siitonen, et al.
Pageof 14